These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3755623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary digoxin-like immunoreactive substance in pregnancy. Relation to urinary electrolytes.
    Friedman HS, Abramowitz I, Nguyen T, Babb B, Stern M, Farrer SM, Tricomi V.
    Am J Med; 1987 Aug; 83(2):261-4. PubMed ID: 3618628
    [Abstract] [Full Text] [Related]

  • 4. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP, Schreiber R, Vogt W, Genz T, Kellner M.
    Klin Padiatr; 1990 Aug; 202(1):31-6. PubMed ID: 2156105
    [Abstract] [Full Text] [Related]

  • 5. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.
    Clerico A, Balzan S, Del Chicca MG, Paci A, Cocci F, Bertelli A.
    Drugs Exp Clin Res; 1988 Aug; 14(9):603-7. PubMed ID: 3229323
    [Abstract] [Full Text] [Related]

  • 6. Increased urinary excretion of digoxin-like immunoreactive substance by insulin-dependent diabetic patients: a linkage with hypertension?
    Giampietro O, Clerico A, Gregori G, Bertoli S, Del Chicca MG, Miccoli R, Lucchetti A, Cruschelli L, Navalesi R.
    Clin Chem; 1988 Dec; 34(12):2418-22. PubMed ID: 3197278
    [Abstract] [Full Text] [Related]

  • 7. Demonstration of a relation between urinary digoxin-like immunoreactive substance and cardiac performance.
    Friedman HS, Babb B, Shim IB, Sotomora G, Farrer SM, Vasavada BC.
    Chest; 1993 Mar; 103(3):878-81. PubMed ID: 8449085
    [Abstract] [Full Text] [Related]

  • 8. Digoxin-like immunoreactive substance in urine of patients with mucocutaneous lymph node syndrome (MCLS).
    Tamura H, Shimoyama S, Sunaga Y, Sakaguchi M, Kuroume T.
    Angiology; 1992 Oct; 43(10):856-65. PubMed ID: 1335703
    [Abstract] [Full Text] [Related]

  • 9. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR, Vorwerk P, Fritsche K, Richter R.
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [Abstract] [Full Text] [Related]

  • 10. Cardiac glycoside-like substance(s): correlations with urinary electrolytes in newborns and in boys.
    Balzan S, Clerico A, Malatino L, Del Chicca MG, Mezzasalma L, Montali U, Ghione S.
    J Nucl Med Allied Sci; 1986 May; 30(4):205-7. PubMed ID: 3585507
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N, Ebara H, Maruyama K, Tomizawa S, Kuroume T.
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood.
    Ebara H, Suzuki S, Nagashima K, Kuroume T.
    Life Sci; 1988 May; 42(3):303-9. PubMed ID: 2826960
    [Abstract] [Full Text] [Related]

  • 15. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
    Gervais A, Nanji AA, Greenway DC, McLean W.
    Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
    [Abstract] [Full Text] [Related]

  • 16. Effects of high altitude exposure on plasma and urinary digoxin-like immunoreactive substance.
    De Angelis C, Farrace S, Urbani L, Porcú S, Ferri C, D'Amelio R, Santucci A, Balsano F.
    Am J Hypertens; 1992 Sep; 5(9):600-7. PubMed ID: 1329852
    [Abstract] [Full Text] [Related]

  • 17. Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy.
    Shrivastav P, Gill DS, D'Souza V, O'Brien PM, Dandona P.
    Clin Chem; 1988 May; 34(5):977-80. PubMed ID: 2967132
    [Abstract] [Full Text] [Related]

  • 18. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
    Bertrand JM, Langhendries JP, Gras A, Battisti O.
    Eur J Pediatr; 1987 Mar; 146(2):145-6. PubMed ID: 3032639
    [Abstract] [Full Text] [Related]

  • 19. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW, Pudek MR, Humphries KH.
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [Abstract] [Full Text] [Related]

  • 20. Role of digoxin-like immunoreactive substance in the pathogenesis of transient tachypnea of newborn.
    Yalaz M, Levent E, Olukman M, Calkavur S, Akisu M, Kultursay N.
    Biomed Res Int; 2013 May; 2013():704763. PubMed ID: 23936837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.